Centogene (CNTG): Net earnings per share (EPS TTM)

centogene.com (CNTG) - corporate logo

A high proportion of fixed costs for genetic testing constrains the operating leverage of Centogene N.V. (CNTG), as illustrated by the TTM earnings per share chart, where the indicator reaches -1.39. Growth potential is driven by an elite staff of bioinformaticians and a unique AI platform for rare diseases, transforming the company into a key B2B hub for global developers of orphan drugs.

CNTG centogene.com Net earnings per share for the last four quarters (07/04/2022 - 08/17/2024)

Analytical breakdowns and data insights for company CENTOGENE, N.V. (CNTG)

- current quotes and average value forecast:
Price Chart CENTOGENE N.V.|CNTG - Analyst Median Target
- stock exchange capitalization data:
Market Capitalization CENTOGENE N.V.|CNTG - Company Buyout Price
- business book valuation details:
Net Assets per Single Share CENTOGENE|CNTG - Book Valuation of Business|Market Capitalization to Book Value Ratio centogene.com|CNTG - Cumulative Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Centogene N.V.|CNTG - Long-Term Liabilities to Capital|Short-Term Debt to Equity Centogene|CNTG - Company Aggregate Debt|Debt to Book Value CENTOGENE N.V.|CNTG - Amount of Long-Term Liabilities|Company Short-Term Debt CENTOGENE|Quick Ratio centogene.com
- earnings and multiples data:
CNTG - Annual Net Income|Projected Future Earnings Centogene N.V.|CNTG - Market Cap to Earnings|Future Price to Earnings CENTOGENE|CNTG - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple CENTOGENE N.V.|CNTG - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months CENTOGENE|CNTG - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months centogene.com|CNTG - Earnings per share growth this year|Expected earnings per share growth for next year Centogene N.V.
Fundamental valuation:centogene.com - CNTG
Manufactured products of Centogene

This indicator is calculated by dividing the total annual net profit by the total number of shares. The metric determines the real return per share, excluding quarterly reporting fluctuations. For Centogene N.V. (CNTG), this figure reflects the efficiency of monetizing unique biodata and the pricing power applied to diagnostics. By analyzing the rolling net profit per share, an investor assesses the balance between current income and development costs.

Who Centogene N.V. competes with

A - Earnings per share for the last twelve months|Net earnings per share for the last four quarters questdiagnostics.com DGX|ILMN: Net earnings per share (EPS TTM)|EXAS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months PerkinElmer|Bio-Rad Corp (BIO) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) NNNN|Net earnings per share for the last 12 months soterahealth.com SHC|Net earnings per share (EPS TTM) QDEL (QuidelOrtho Corporation)|OPKO Health Inc (OPK) - Net earnings per one share for the last twelve months|CDNA - Earnings per share for the last twelve months|MRVI (Maravai) - Earnings per share for the last 12 months|FLGT (Fulgent Genetics, Inc.) - Net earnings per share for the last 12 months|LAB: Earnings per share for the last four quarters|Earnings per share for the last twelve months Cytek Biosciences|Net earnings per one share for the last twelve months OraSure Technologies, Inc. OSUR|Net earnings per share (EPS TTM) XGN|MDxHealth, Inc. (MDXH) - Net earnings per share for the trailing year|Net earnings per share (EPS TTM) LUCD (Lucid Diagnostics Inc.)|Prenetics Global Limited (PRE) - Net earnings per one share for the last twelve months|IMDX - Earnings per share for the last twelve months|TRIB (Trinity Biotech plc) - Earnings per share for the last 12 months|PRPH: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Ainos Corporation (AIMD)|Net earnings per share for the last 12 months CODX|HSCS: Earnings per share for the trailing year|Earnings per share for the last twelve months Biomerica (BMRA)|cardiodiagnosticsinc.com - Earnings per share for the last 12 months|Onconetix Corp - Net earnings per share for the last 12 months|Net earnings per share for the last four quarters Virax Biolabs Corp (VRAX)|BJDX: Net earnings per share for the last 12 months|AWH: Earnings per share for the last twelve months|AXDX (Accelerate Diagnostics, Inc.) - Net earnings per share for the last 12 months|ENZ - Net earnings per share for the last four quarters|FRES (Fresh2 Group Ltd) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months GTG Labs (GENE)|Earnings per share for the last twelve months 23andMe Holding Co. (ME)|psychemedics.com - Earnings per share for the last 12 months